Durham biopharma lands $7M to develop ‘muco-trapping’ antibody platform
Date Published:
Inhalon Biopharma is developing a “muco-trapping” antibody platform that could be used to treat acute respiratory infections, including COVID-19, and the…
COVID-19
Execs at RDU’s big airlines increasingly confident of faster recovery for business travel
Date Published:
Scott Kirby, CEO of American Airlines states that business demand for travel has already started increasing, and he expects to…
Durham biopharma lands $7M to develop ‘muco-trapping’ antibody platform
Date Published:
by WRAL TechWire — May 26, 2021 .
Inhalon Biopharma is developing a “muco-trapping” antibody platform that could be used…
Duke scientists develop new potential coronavirus vaccine – it’s already effective in animal studies
Date Published:
by Sarah Avery
A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in…
New tech jobs report finds 22 percent increase in IT jobs compared to last year
Date Published:
by Jason Parker — April 20, 2021
One year after the onset of the novel coronavirus pandemic and the spread…
Duke-led team predicts two COVID vaccines to protect from CA variant
Date Published:
by Duke Health — April 8, 2021 .
Two different COVID vaccines are predicted to be protective against a rapidly…
North Carolina ranks No. 2 for working from home, new study says
Date Published:
by WRAL TechWire — April 6, 2021
North Carolina has another accolade to use when recruiting businesses to locate here…
Durham drug startup to target variety of therapies with $155M in new funding
Date Published:
by Chantal Allam, NCBiotech writer
Brii Biosciences is plowing ahead with its clinical development programs after landing a whooping $155 million…
Merck Confirms J&J COVID-19 Vaccine Includes Durham Site
Date Published:
By NC Biotech
Global pharmaceutical giant Merck has confirmed that its flagship Durham vaccine manufacturing facility is gearing up to…